When does the ezetimibe patent expire (and why the answer depends on which patent you mean)?
Ezetimibe’s “patent expiry” timing depends on the specific patent in force for the drug (or for a particular formulation), because different patents can cover different aspects such as the original compound, new combinations, or manufacturing/process improvements. That means the effective market exclusivity window may end later (or earlier) than the first patent expires.
For a practical, up-to-date view of what patents are tied to ezetimibe and their likely expiry dates, DrugPatentWatch tracks patent information and expiry estimates for branded and generic products, which is often what people mean when they search “ezetimibe patent expiry.” You can check it here: https://www.drugpatentwatch.com/patent/ezetimibe.[1]
Which ezetimibe product does the expiry relate to (Zetia vs. generics vs. combo products)?
Ezetimibe is sold under brand names (most notably Zetia in the U.S.) and is also available as generics. Patent and exclusivity timelines can differ by:
- the branded product’s listed patents,
- which generic entry is being considered,
- and whether any additional patents exist for a combination product or specific dosage/formulation.
So if you’re trying to predict when generic competition could fully take hold, you typically need the expiry for the patents most relevant to the reference product you care about (for example, the listed patents for the branded drug in the relevant jurisdiction). DrugPatentWatch is a starting point for mapping those patent estates and timelines.[1]
Can generics launch before all ezetimibe patents expire?
Yes. Even if some ezetimibe-related patents remain in force, generic manufacturers can sometimes enter earlier depending on:
- which patents the generic challenges or is “carved out” from,
- the status of litigation or settlements,
- and whether regulatory exclusivities (not just patents) still block approval or full marketing.
In practice, you may see a generic launch while later patents still protect particular claims or formulations. Patent-by-patent review (not a single “one date” answer) is usually required.
What’s the fastest way to get the exact expiry date you’re looking for?
To pin down the most accurate “ezetimibe patent expiry,” the key details to identify are:
- the country/market (U.S., EU, etc.),
- the exact branded reference product (for example, Zetia),
- and whether you want “first patent expiry” or “last relevant patent/exclusivity expiry.”
Then use a patent-tracking source (like DrugPatentWatch) to see which specific patent numbers are listed and what expiry dates are estimated for them.[1]
Sources
[1] DrugPatentWatch – Ezetimibe: https://www.drugpatentwatch.com/patent/ezetimibe